Want to see IN:IOLCP full AI Analyst Report?
Total Valuation
IOL Chemicals & Pharmaceuticals Ltd. has a market cap or net worth of ₹51.25B. The enterprise value is ₹20.69B.
Market Cap₹51.25B
Enterprise Value₹20.69B
Share Statistics
IOL Chemicals & Pharmaceuticals Ltd. has 293,527,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding293,527,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
IOL Chemicals & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 6.94%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.94%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee6.46M
Profits Per Employee383.18K
Employee Count3,592
Asset Turnover0.90
Inventory Turnover4.89
Valuation Ratios
The current PE Ratio of IOL Chemicals & Pharmaceuticals Ltd. is 30.5. IOL Chemicals & Pharmaceuticals Ltd.’s PEG ratio is 0.43.
PE Ratio30.5
PS Ratio0.92
PB Ratio1.19
Price to FCF55.57
Price to Operating Cash Flow454.78
PEG Ratio0.43
Income Statement
In the last 12 months, IOL Chemicals & Pharmaceuticals Ltd. had revenue of 23.19B and earned 1.38B in profits. Earnings per share was 4.69.
Revenue23.19B
Gross Profit5.03B
Operating Income1.89B
Pretax Income1.84B
Net Income1.38B
EBITDA2.69B
Earnings Per Share (EPS)4.69
Cash Flow
In the last 12 months, operating cash flow was 110.60M and capital expenditures -646.30M, giving a free cash flow of -535.70M billion.
Operating Cash Flow110.60M
Free Cash Flow-535.70M
Free Cash Flow per Share-1.83
Dividends & Yields
IOL Chemicals & Pharmaceuticals Ltd. pays an annual dividend of ₹1, resulting in a dividend yield of 0.57%
Dividend Per Share₹1
Dividend Yield0.57%
Payout Ratio17.46%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.45
52-Week Price Change82.88%
50-Day Moving Average191.12
200-Day Moving Average126.10
Relative Strength Index (RSI)35.10
Average Volume (3m)235.66K
Important Dates
IOL Chemicals & Pharmaceuticals Ltd. upcoming earnings date is Nov 18, 2026, TBA (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
IOL Chemicals & Pharmaceuticals Ltd. as a current ratio of 1.78, with Debt / Equity ratio of 0.00%
Current Ratio1.78
Quick Ratio1.24
Debt to Market Cap0.06
Net Debt to EBITDA0.26
Interest Coverage Ratio12.97
Taxes
In the past 12 months, IOL Chemicals & Pharmaceuticals Ltd. has paid 467.20M in taxes.
Income Tax467.20M
Effective Tax Rate0.25
Enterprise Valuation
IOL Chemicals & Pharmaceuticals Ltd. EV to EBITDA ratio is 8.20, with an EV/FCF ratio of 57.39.
EV to Sales0.95
EV to EBITDA8.20
EV to Free Cash Flow57.39
EV to Operating Cash Flow10.43
Balance Sheet
IOL Chemicals & Pharmaceuticals Ltd. has ₹2.00B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹2.00B billion.
Cash & Marketable Securities₹2.00B
Total Debt₹0.00
Net Cash₹2.00B
Net Cash Per Share₹6.82
Tangible Book Value Per Share₹60.78
Margins
Gross margin is 19.89%, with operating margin of 8.14%, and net profit margin of 5.94%.
Gross Margin19.89%
Operating Margin8.14%
Pretax Margin7.95%
Net Profit Margin5.94%
EBITDA Margin11.60%
EBIT Margin8.14%
Analyst Forecast
The average price target for IOL Chemicals & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.56%
EPS Growth Forecast60.06%